Respiratory Protection Against Hazardous Biological Agents
portes grátis
Respiratory Protection Against Hazardous Biological Agents
Okrasa, Malgorzata; Szulc, Justyna; Majchrzycka, Katarzyna
Taylor & Francis Ltd
02/2022
170
Mole
Inglês
9780367497002
15 a 20 dias
453
Descrição não disponível.
1. Introduction. 2. Biological Agents. 3. Principles of Biosafety in the Working Environment. 4. Personal Respiratory Protection. 5. Ways to Improve the Safety of Filtering Respiratory Protective Devices Against Bioaerosols. 6. Good Practices for the Selection and Use of Respiratory Protective Devices.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Filtering Half Masks;Harmful Biological Agent;respiratory protection;RPD;filtering materials;Filtering Material;bioaerosol sampling;Half Masks;Biological Agents;Faceseal Leakage;CFR;Predictive Microbiology;Non-biological Particles;Protection Class;PPE Item;Sodium Chloride Aerosol;DNA Protein Crosslinks;Filtering Nonwovens;Filtration Efficiency;Breathing Simulation;Moisture Content;Biocidal Properties;Surgical Masks;EHF;German Social Accident Insurance;Biocidal Product;Lag Phase Duration;NIPH
1. Introduction. 2. Biological Agents. 3. Principles of Biosafety in the Working Environment. 4. Personal Respiratory Protection. 5. Ways to Improve the Safety of Filtering Respiratory Protective Devices Against Bioaerosols. 6. Good Practices for the Selection and Use of Respiratory Protective Devices.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Filtering Half Masks;Harmful Biological Agent;respiratory protection;RPD;filtering materials;Filtering Material;bioaerosol sampling;Half Masks;Biological Agents;Faceseal Leakage;CFR;Predictive Microbiology;Non-biological Particles;Protection Class;PPE Item;Sodium Chloride Aerosol;DNA Protein Crosslinks;Filtering Nonwovens;Filtration Efficiency;Breathing Simulation;Moisture Content;Biocidal Properties;Surgical Masks;EHF;German Social Accident Insurance;Biocidal Product;Lag Phase Duration;NIPH
